Farhan A. Irshad, MD FACS and the Eye Clinic of Austin team are excited to announce the arrival of an innovative new procedure for Glaucoma patients – the iStent inject®.
As we move into 2018, we take the month of January to spread awareness about a leading cause of blindness in the US – glaucoma. Glaucoma is called the “sneak thief of sight” because early on in the disease’s progression, there are no symptoms.
Celebrities have eye problems as often as the rest of us. When Bono shared his experience with glaucoma, he said that he had been dealing with it for many years. He demonstrates how people with glaucoma can keep their sight and continue to lead a normal life if treated early enough.
It turns out that your mother was right – about many things – but particularly about the importance of eating your vegetables. There have been many articles in recent years about the importance of multiple servings of vegetables in reducing the risk of a number of diseases.
Although genetics plays a role in an individual developing glaucoma, studies have shown that certain lifestyle choices may decrease your risk for the eye disease.
Rho kinase inhibitors are a new class of glaucoma drugs currently in clinical trials. Rho kinase (dubbed “ROCK”) inhibitors promise to act specifically on the eye’s drainage canals (called the trabecular meshwork) a main outflow and blockage site in glaucoma.